Skip to main content
. 2017;18(3):857–861. doi: 10.22034/APJCP.2017.18.3.857

Table 4.

Combination of ERCC1 and CTR1 Polymorphisms and Both Response Rate and Tumor Control [n (%)]

N=26 Responders Non-resonders P-value
(CR+PR) (SD+PD) (Fisher’s exact test)
GG/CC 2 (50.0) 2 (50.0) 0.018
The others 0 (0.0) 22 (100.0)
Tumor control (PR+SD) Progressive disease (PD)
GG/CC 3 (75.0) 1 (25.0) 1.000
The others 16 (72.7) 6 (27.3)